CD40 and autoimmunity: The dark side of a great activator
- 11 July 2009
- journal article
- review article
- Published by Elsevier in Seminars in Immunology
- Vol. 21 (5), 293-300
- https://doi.org/10.1016/j.smim.2009.05.012
Abstract
No abstract availableKeywords
This publication has 132 references indexed in Scilit:
- Genetic risk factors for rheumatoid arthritis differ in caucasian and Korean populationsArthritis & Rheumatism, 2009
- CD40–CD40L cross-talk integrates strong antigenic signals and microbial stimuli to induce development of IL-17-producing CD4 + T cellsProceedings of the National Academy of Sciences, 2009
- Evidence that cytokines play a role in rheumatoid arthritisJCI Insight, 2008
- Autoimmune diseases: insights from genome-wide association studiesHuman Molecular Genetics, 2008
- Common variants at CD40 and other loci confer risk of rheumatoid arthritisNature Genetics, 2008
- The CD40, CTLA-4, thyroglobulin, TSH receptor, and PTPN22 gene quintet and its contribution to thyroid autoimmunity: Back to the futureJournal of Autoimmunity, 2007
- Analysis of the C/T−1 single nucleotide polymorphism in the CD40 gene in multiple sclerosisTissue Antigens, 2006
- Efficacy of rituximab (anti-CD20) for refractory systemic lupus erythematosus involving the central nervous systemAnnals Of The Rheumatic Diseases, 2006
- Fine-Mapping Chromosome 20 in 230 Systemic Lupus Erythematosus Sib Pair and Multiplex Families: Evidence for Genetic Epistasis with Chromosome 16q12American Journal of Human Genetics, 2006
- Safety and tolerability of antagonist anti‐human CD40 Mab ch5D12 in patients with moderate to severe Crohn's diseaseAlimentary Pharmacology & Therapeutics, 2005